Acquisition / mergerFiled on BSE ·
Gujarat Themis Biosyn Ltd. completes acquisition of MicroBiopharm Japan Co., Ltd.
Guj. Themis Bio. · Pharmaceuticals & Biotechnology
What the filing says
- Acquired 100% equity of MicroBiopharm Japan Co., Ltd. via Themis Biosyn Japan Limited on 18 Sept 2026
- Investment comprises ₹475 crore capital contribution and ₹745 crore loan to Themis Biosyn Japan Limited
- Loan agreement up to ₹800 crore entered between GTBL and its Japanese wholly owned subsidiary for acquisition funding
Original filing
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue: Rank 1Margin: Rank 1
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Guj. Themis Bio.
- Fundraise / allotmentGujarat Themis Biosyn Ltd allots ₹585 crore NCDs via private placement on 16-09-2026
- Fundraise / allotmentGujarat Themis Biosyn approves issuance of Non-Convertible Debentures up to ₹585 Cr
- Fundraise / allotmentGujarat Themis Biosyn Ltd announces Board meeting on September 10, 2026
Other acquisition / merger filings this fortnight
- Acquisition / mergerTPL Plastech LtdTPL Plastech Limited to merge with Time Technoplast Limited; share exchange ratio approved
- Acquisition / mergerTPL Plastech LtdTPL Plastech Limited approves merger with Time Technoplast Limited
- Acquisition / mergerNiyogin Fintech LtdNiyogin Fintech schedules meetings for Scheme of Arrangement on Oct 30, 2026
- Acquisition / mergerVasa DenticityVasa Denticity Ltd cancels proposed 31.08% acquisition in IDS Denmed Pvt Ltd
- Acquisition / mergerKronox Lab Sciences LtdKronox Lab Sciences Ltd: Completion of 64.26% share transfer and promoter change
- Acquisition / mergerKronox Lab Sciences LtdKronox Lab Sciences Ltd announces share sale, director resignations, and appointments
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.